Cybin Inc. (CYBN) — Cybin completed its previously announced registered direct offering, confirming the roughly $175 million raise closed on October 31.
The proceeds retire the company's High Trail convertible debentures and fund continued clinical development. The completed financing removed a debt overhang and extended Cybin's runway into its pivotal trial readouts.
Source: ir.helus.com
For the rest of that week's sector news, read our week in review.